Skip to main content
. Author manuscript; available in PMC: 2013 Dec 26.
Published in final edited form as: J Immunol. 2011 Jan 10;186(4):2482–2494. doi: 10.4049/jimmunol.0903634

Figure 4.

Figure 4

Differential distribution of CCL2 and CXCL1 mRNA in nuclear and cytoplasmic compartments in cytokine-treated BEAS-2B cells. Levels of nuclear and cytoplasmic CCL2 and CXCL1 mRNA detected by real-time PCR in BEAS-2B cells treated with TNF-α plus IFN-γ (50 ng/ml each) for 3 and 18 h (n = 2).